Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis

Detalhes bibliográficos
Autor(a) principal: de Souza, Helton Luis [UNESP]
Data de Publicação: 2012
Outros Autores: de Carvalho, Vanessa R. [UNESP], Romeiro, Fernando Gomes [UNESP], Sassaki, Ligia Yukie [UNESP], Keller, Rogeria [UNESP], Rodrigues, Josias [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1186/1757-4749-4-21
http://hdl.handle.net/11449/18278
Resumo: Background: Escherichia coli is believed to participate in the etiology of Crohn's disease (CD) and possibly of ulcerative colitis (UC), due at least in part to the observed rise in the number of these bacteria in the gut microbiota of CD and UC patients. Nevertheless, it is not fully understood whether this quantitative variation occurs equally throughout the mucosal and luminal spaces of the gut. To assess this question, stools and mucosa biopsies from distinct intestinal sites were cultured aiming at determining their E. coli concentration. The cultures were additionally screened for the presence of some virulence genes of pathogenic E. coli.Results: Analyses of clinical materials from 14 controls (38 biopsies and 14 stools samples), 11 CD (25 biopsies and 11 stools samples) and 7 UC patients (18 biopsies and 7 stools samples) indicated no significant variation in the number of E. coli present in stools, but a rise of at least one log(10) CFU/mg in biopsies from the ileum of CD patients and the sigmoid and rectum of CD and UC patients. The cultures were screened for the presence of E. coli attaching and effacing (eae), invasion plasmid antigen H (ipaH), aggregative adherence transcriptional activator (aggR), Shiga cytotoxins (stx), and heat labile enterotoxin (elt) and the following serine proteases autotransporters of Enterobacteriaceae (SPATE) genes: plasmid encoded toxin (pet), secreted autotransporter toxin (sat), Shigella extracellular protein (sepA), protein involved in intestinal colonization (pic) and Shigella IgA-like protease homolog (sigA). Six of the 10 genes screened were detected in the total of samples investigated: aggR, eae, pet, sat, sepA and sigA. No difference in the prevalence of any of these markers was observed in cultures from different clinical materials or groups of patients.Methods: Bacterial quantitation was carried out following cultures of diluted samples suspensions in MacConkey agar, Wilkins Chalgren agar for anaerobes, E. coli/coliform chromocult agar, and blood agar. Screening for E. coli virulence genes was performed by multiplex PCR of DNA purified from total MacConkey undiluted broth cultures.Conclusion: In CD and UC patients only the mucosa associated population of E. coli is augmented and the proliferation is prominent in the ileum of CD and rectum and sigmoid of both UC and CD patients which are sites where the lesions usually are observed. The augmented E. coli population in these sites presented a low number of the virulence markers, possibly meaning that they are not relevant for the disease process.
id UNSP_0dd9e673cdbe3d428a57e813bae254fc
oai_identifier_str oai:repositorio.unesp.br:11449/18278
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitisEscherichia coliBacteriaVirulenceCrohn's diseaseUlcerative colitisBackground: Escherichia coli is believed to participate in the etiology of Crohn's disease (CD) and possibly of ulcerative colitis (UC), due at least in part to the observed rise in the number of these bacteria in the gut microbiota of CD and UC patients. Nevertheless, it is not fully understood whether this quantitative variation occurs equally throughout the mucosal and luminal spaces of the gut. To assess this question, stools and mucosa biopsies from distinct intestinal sites were cultured aiming at determining their E. coli concentration. The cultures were additionally screened for the presence of some virulence genes of pathogenic E. coli.Results: Analyses of clinical materials from 14 controls (38 biopsies and 14 stools samples), 11 CD (25 biopsies and 11 stools samples) and 7 UC patients (18 biopsies and 7 stools samples) indicated no significant variation in the number of E. coli present in stools, but a rise of at least one log(10) CFU/mg in biopsies from the ileum of CD patients and the sigmoid and rectum of CD and UC patients. The cultures were screened for the presence of E. coli attaching and effacing (eae), invasion plasmid antigen H (ipaH), aggregative adherence transcriptional activator (aggR), Shiga cytotoxins (stx), and heat labile enterotoxin (elt) and the following serine proteases autotransporters of Enterobacteriaceae (SPATE) genes: plasmid encoded toxin (pet), secreted autotransporter toxin (sat), Shigella extracellular protein (sepA), protein involved in intestinal colonization (pic) and Shigella IgA-like protease homolog (sigA). Six of the 10 genes screened were detected in the total of samples investigated: aggR, eae, pet, sat, sepA and sigA. No difference in the prevalence of any of these markers was observed in cultures from different clinical materials or groups of patients.Methods: Bacterial quantitation was carried out following cultures of diluted samples suspensions in MacConkey agar, Wilkins Chalgren agar for anaerobes, E. coli/coliform chromocult agar, and blood agar. Screening for E. coli virulence genes was performed by multiplex PCR of DNA purified from total MacConkey undiluted broth cultures.Conclusion: In CD and UC patients only the mucosa associated population of E. coli is augmented and the proliferation is prominent in the ileum of CD and rectum and sigmoid of both UC and CD patients which are sites where the lesions usually are observed. The augmented E. coli population in these sites presented a low number of the virulence markers, possibly meaning that they are not relevant for the disease process.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)State Univ São Paulo UNESP, Dept Microbiol & Immunol, Inst Biosci, Lab Med Bacteriol, BR-18618970 Botucatu, SP, BrazilState Univ São Paulo UNESP, Dept Internal Med, Botucatu Med Sch, BR-18618970 Botucatu, SP, BrazilState Univ São Paulo UNESP, Dept Microbiol & Immunol, Inst Biosci, Lab Med Bacteriol, BR-18618970 Botucatu, SP, BrazilState Univ São Paulo UNESP, Dept Internal Med, Botucatu Med Sch, BR-18618970 Botucatu, SP, BrazilFAPESP: 08/10975-0Biomed Central Ltd.Universidade Estadual Paulista (Unesp)de Souza, Helton Luis [UNESP]de Carvalho, Vanessa R. [UNESP]Romeiro, Fernando Gomes [UNESP]Sassaki, Ligia Yukie [UNESP]Keller, Rogeria [UNESP]Rodrigues, Josias [UNESP]2014-05-20T13:51:11Z2014-05-20T13:51:11Z2012-12-13info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article8application/pdfhttp://dx.doi.org/10.1186/1757-4749-4-21Gut Pathogens. London: Biomed Central Ltd., v. 4, p. 8, 2012.1757-4749http://hdl.handle.net/11449/1827810.1186/1757-4749-4-21WOS:000314989200001WOS000314989200001.pdf42114321288164094734747821898178Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengGut Pathogens2.8091,066info:eu-repo/semantics/openAccess2024-08-14T17:22:49Zoai:repositorio.unesp.br:11449/18278Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-14T17:22:49Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis
title Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis
spellingShingle Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis
de Souza, Helton Luis [UNESP]
Escherichia coli
Bacteria
Virulence
Crohn's disease
Ulcerative colitis
title_short Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis
title_full Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis
title_fullStr Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis
title_full_unstemmed Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis
title_sort Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis
author de Souza, Helton Luis [UNESP]
author_facet de Souza, Helton Luis [UNESP]
de Carvalho, Vanessa R. [UNESP]
Romeiro, Fernando Gomes [UNESP]
Sassaki, Ligia Yukie [UNESP]
Keller, Rogeria [UNESP]
Rodrigues, Josias [UNESP]
author_role author
author2 de Carvalho, Vanessa R. [UNESP]
Romeiro, Fernando Gomes [UNESP]
Sassaki, Ligia Yukie [UNESP]
Keller, Rogeria [UNESP]
Rodrigues, Josias [UNESP]
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv de Souza, Helton Luis [UNESP]
de Carvalho, Vanessa R. [UNESP]
Romeiro, Fernando Gomes [UNESP]
Sassaki, Ligia Yukie [UNESP]
Keller, Rogeria [UNESP]
Rodrigues, Josias [UNESP]
dc.subject.por.fl_str_mv Escherichia coli
Bacteria
Virulence
Crohn's disease
Ulcerative colitis
topic Escherichia coli
Bacteria
Virulence
Crohn's disease
Ulcerative colitis
description Background: Escherichia coli is believed to participate in the etiology of Crohn's disease (CD) and possibly of ulcerative colitis (UC), due at least in part to the observed rise in the number of these bacteria in the gut microbiota of CD and UC patients. Nevertheless, it is not fully understood whether this quantitative variation occurs equally throughout the mucosal and luminal spaces of the gut. To assess this question, stools and mucosa biopsies from distinct intestinal sites were cultured aiming at determining their E. coli concentration. The cultures were additionally screened for the presence of some virulence genes of pathogenic E. coli.Results: Analyses of clinical materials from 14 controls (38 biopsies and 14 stools samples), 11 CD (25 biopsies and 11 stools samples) and 7 UC patients (18 biopsies and 7 stools samples) indicated no significant variation in the number of E. coli present in stools, but a rise of at least one log(10) CFU/mg in biopsies from the ileum of CD patients and the sigmoid and rectum of CD and UC patients. The cultures were screened for the presence of E. coli attaching and effacing (eae), invasion plasmid antigen H (ipaH), aggregative adherence transcriptional activator (aggR), Shiga cytotoxins (stx), and heat labile enterotoxin (elt) and the following serine proteases autotransporters of Enterobacteriaceae (SPATE) genes: plasmid encoded toxin (pet), secreted autotransporter toxin (sat), Shigella extracellular protein (sepA), protein involved in intestinal colonization (pic) and Shigella IgA-like protease homolog (sigA). Six of the 10 genes screened were detected in the total of samples investigated: aggR, eae, pet, sat, sepA and sigA. No difference in the prevalence of any of these markers was observed in cultures from different clinical materials or groups of patients.Methods: Bacterial quantitation was carried out following cultures of diluted samples suspensions in MacConkey agar, Wilkins Chalgren agar for anaerobes, E. coli/coliform chromocult agar, and blood agar. Screening for E. coli virulence genes was performed by multiplex PCR of DNA purified from total MacConkey undiluted broth cultures.Conclusion: In CD and UC patients only the mucosa associated population of E. coli is augmented and the proliferation is prominent in the ileum of CD and rectum and sigmoid of both UC and CD patients which are sites where the lesions usually are observed. The augmented E. coli population in these sites presented a low number of the virulence markers, possibly meaning that they are not relevant for the disease process.
publishDate 2012
dc.date.none.fl_str_mv 2012-12-13
2014-05-20T13:51:11Z
2014-05-20T13:51:11Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1757-4749-4-21
Gut Pathogens. London: Biomed Central Ltd., v. 4, p. 8, 2012.
1757-4749
http://hdl.handle.net/11449/18278
10.1186/1757-4749-4-21
WOS:000314989200001
WOS000314989200001.pdf
4211432128816409
4734747821898178
url http://dx.doi.org/10.1186/1757-4749-4-21
http://hdl.handle.net/11449/18278
identifier_str_mv Gut Pathogens. London: Biomed Central Ltd., v. 4, p. 8, 2012.
1757-4749
10.1186/1757-4749-4-21
WOS:000314989200001
WOS000314989200001.pdf
4211432128816409
4734747821898178
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Gut Pathogens
2.809
1,066
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 8
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd.
publisher.none.fl_str_mv Biomed Central Ltd.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128137466216448